Currently out of the existing stock ratings of Gavin Clark-Gartner, 73 are a BUY (94.81%), 4 are a HOLD (5.19%).

Gavin Clark-Gartner

Work Performance Price Targets & Ratings Chart

Analyst Gavin Clark-Gartner, currently employed at EVERCORE, carries an average stock price target met ratio of 44.54% that have a potential upside of 48.53% achieved within 94 days.

Gavin Clark-Gartner’s has documented 154 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TENX, at 11-Aug-2026.

Wall Street Analyst Gavin Clark-Gartner

Analyst best performing recommendations are on LBPH (LONGBOARD PHARMACEUTICALS).
The best stock recommendation documented was for LBPH (LONGBOARD PHARMACEUTICALS) at 12/22/2023. The price target of $25 was fulfilled within 11 days with a profit of $19 (316.67%) receiving and performance score of 287.88.

Average potential price target upside

ABBV AbbVie ARGX argenx NV ADR ATXS Astria Therapeutics BCRX BioCryst Pharmaceuticals CABA Cabaletta Bio INSM Insmed MIRM Mirum Pharmaceuticals MNMD Mind Medicine RNA Avidity Biosciences SRPT Sarepta Therapeutics TVTX Travere Therapeutics ACRS Aclaris Therapeutics CMPS Compass Pathways Plc CRNX Crinetics Pharmaceuticals DYN Dyne Therapeutics INCY yte KRYS Krystal Biotech LBPH Longboard Pharmaceuticals MGTX MeiraGTx Holdings PLC PRQR ProQR Therapeutics BV TENX VERA Vera Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Sep-2026

$315

$52.18 (19.85%)

$265

25 days ago
(10-Sep-2026)

6/7 (85.71%)

$60 (23.53%)

115

Buy Since 12-Sep-2025

$303

$40.18 (15.29%)

$298

1 months 15 days ago
(20-Aug-2026)

2/11 (18.18%)

$41.17 (15.72%)

35

Buy Since 09-Dec-2021

$300

$37.18 (14.15%)

$295

1 months 18 days ago
(17-Aug-2026)

14/16 (87.5%)

$49.67 (19.84%)

506

Hold Since 13-Aug-2026

$300

$37.18 (14.15%)

1 months 22 days ago
(13-Aug-2026)

1/2 (50%)

$49.18 (19.61%)

115

Buy Since 23-Jan-2023

$260

$-2.82 (-1.07%)

$235

1 months 25 days ago
(10-Aug-2026)

9/9 (100%)

$12.03 (4.85%)

133

Show more analysts

Please expand the browser size to see the chart

Which stock is Gavin Clark-Gartner most bullish on?

Potential upside of $139.79 has been obtained for ARGX (ARGENX NV ADR)

Which stock is Gavin Clark-Gartner most reserved on?

Potential downside of -$22.28 has been obtained for KRYS (KRYSTAL BIOTECH)

What Year was the first public recommendation made by Gavin Clark-Gartner?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?